|
Volumn 19, Issue 2, 2001, Pages 133-151
|
Multilateral in vivo and in vitro protective effects of the novel heat shock protein coinducer, bimoclomol: Results of preclinical studies
|
Author keywords
Angiopathy; Cardiac contraction; Cytoprotection; Diabetes; Heat shock proteins; Ischemic injury; Vasodilation
|
Indexed keywords
ACETYLCHOLINE;
BIMOCLOMOL;
BRLP 42;
CALCIUM ION;
GAMMA LINOLENIC ACID;
HEAT SHOCK PROTEIN;
HEAT SHOCK PROTEIN 70;
HYDROXYLAMINE;
PROTECTIVE AGENT;
RYANODINE RECEPTOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIARRHYTHMIC ACTIVITY;
BLOOD BRAIN BARRIER;
CALCIUM CELL LEVEL;
CELL PROTECTION;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
DIABETIC NEUROPATHY;
DIABETIC RETINOPATHY;
DOG;
DRUG METABOLISM;
HEART MUSCLE CONTRACTILITY;
HEART MUSCLE ISCHEMIA;
HEART PROTECTION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
MAJOR CLINICAL STUDY;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROTEIN INDUCTION;
RAT;
REVIEW;
VASCULAR DISEASE;
VASODILATATION;
WOUND HEALING;
|
EID: 0034894697
PISSN: 08975957
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1527-3466.2001.tb00060.x Document Type: Review |
Times cited : (39)
|
References (49)
|